Literature DB >> 22109744

Quantitative histological-hemodynamic correlations in cirrhosis.

Supatsri Sethasine1, Dhanpat Jain, Roberto J Groszmann, Guadalupe Garcia-Tsao.   

Abstract

UNLABELLED: We have previously shown, in a semiquantitative analysis of liver biopsies showing cirrhosis, that thickness of fibrous septa separating cirrhotic nodules and small size of cirrhotic nodules correlated independently with portal pressure (as determined by the hepatic venous pressure gradient; HVPG) and were independent predictors of the presence of clinically significant portal hypertension (PH). This study aimed to confirm these results using quantitative analysis of these biopsies using digital image analysis. Biopsies of 42 patients with cirrhosis and HVPG measurements within 6 months of the biopsy were included in the study. The following parameters were scored quantitatively and without knowledge of HVPG results: total fibrosis area, septal thickness, nodule size, and number of nodules per millimeter of length of liver biopsy. Fibrosis area was the only parameter that independently correlated with HVPG (r = 0.606; P < 0.0001). Correlation was significant, even among patients with clinically significant PH (r = 0.636; P < 0.005). Fibrosis area and nodule size were both independently predictive of the presence of clinically significant PH (r = 0.57; P = 0.003).
CONCLUSIONS: On quantitative analysis, fibrosis area was the parameter that correlated best with HVPG and the presence of clinically significant PH. Beyond pathophysiological implications, this also has methodological implications that are discussed in this article.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22109744      PMCID: PMC3721182          DOI: 10.1002/hep.24805

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

Review 1.  The hepatic venous pressure gradient: anything worth doing should be done right.

Authors:  Roberto J Groszmann; Suchat Wongcharatrawee
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

2.  Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

Authors:  Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Norman D Grace; Andrew K Burroughs; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Hong Gao; Robert Makuch
Journal:  N Engl J Med       Date:  2005-11-24       Impact factor: 91.245

3.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.

Authors:  Francesco Vizzutti; Umberto Arena; Roberto G Romanelli; Luigi Rega; Marco Foschi; Stefano Colagrande; Antonio Petrarca; Stefania Moscarella; Giacomo Belli; Anna Linda Zignego; Fabio Marra; Giacomo Laffi; Massimo Pinzani
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

4.  Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis.

Authors:  Satish Nagula; Dhanpat Jain; Roberto J Groszmann; Guadalupe Garcia-Tsao
Journal:  J Hepatol       Date:  2005-09-23       Impact factor: 25.083

5.  Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.

Authors:  P S Bhathal; H J Grossman
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

6.  Increased blood flow through the portal system in cirrhotic rats.

Authors:  J Vorobioff; J E Bredfeldt; R J Groszmann
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

7.  Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies.

Authors:  M Kage; K Shimamatu; E Nakashima; M Kojiro; O Inoue; M Yano
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

8.  Correlations between sinusoidal pressure and liver morphology in cirrhosis.

Authors:  R Picchiotti; P L Mingazzini; L Scucchi; M Bressan; D Di Stefano; M Donnetti; L Feroci
Journal:  J Hepatol       Date:  1994-03       Impact factor: 25.083

9.  Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

Authors:  Cristina Ripoll; Roberto Groszmann; Guadalupe Garcia-Tsao; Norman Grace; Andrew Burroughs; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; Robert Makuch; David Patch; Daniel S Matloff; Jaime Bosch
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

10.  Sampling variability of liver fibrosis in chronic hepatitis C.

Authors:  Pierre Bedossa; Delphine Dargère; Valerie Paradis
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  23 in total

1.  Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension.

Authors:  Noelle H Ebel; Kristen Carlin; Michele L Shaffer; Giri Shivaram; Matthew Hawkins; Erin R Lane; Kara Cooper; Will S Lindquester; Gaurav Gadodia; Karen F Murray
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-06       Impact factor: 2.839

Review 2.  Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.

Authors:  Natalie J Torok; Jonathan A Dranoff; Detlef Schuppan; Scott L Friedman
Journal:  Hepatology       Date:  2015-03-10       Impact factor: 17.425

Review 3.  Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 4.  Molecular prognostic prediction in liver cirrhosis.

Authors:  Nicolas Goossens; Shigeki Nakagawa; Yujin Hoshida
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

5.  Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.

Authors:  M J Nielsen; J Lehmann; D J Leeming; R Schierwagen; S Klein; C Jansen; C P Strassburg; F Bendtsen; S Møller; T Sauerbruch; M A Karsdal; A Krag; J Trebicka
Journal:  Dig Dis Sci       Date:  2015-07-03       Impact factor: 3.199

6.  qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients.

Authors:  Shuoyu Xu; Yan Wang; Dean C S Tai; Shi Wang; Chee Leong Cheng; Qiwen Peng; Jie Yan; Yongpeng Chen; Jian Sun; Xieer Liang; Youfu Zhu; Jagath C Rajapakse; Roy E Welsch; Peter T C So; Aileen Wee; Jinlin Hou; Hanry Yu
Journal:  J Hepatol       Date:  2014-02-26       Impact factor: 25.083

7.  Role of magnetic resonance elastography in compensated and decompensated liver disease.

Authors:  Sumeet K Asrani; Jayant A Talwalkar; Patrick S Kamath; Vijay H Shah; Giovanna Saracino; Linda Jennings; John B Gross; Sudhakar Venkatesh; Richard L Ehman
Journal:  J Hepatol       Date:  2013-12-19       Impact factor: 25.083

8.  Hydrogels with differential and patterned mechanics to study stiffness-mediated myofibroblastic differentiation of hepatic stellate cells.

Authors:  Murat Guvendiren; Maryna Perepelyuk; Rebecca G Wells; Jason A Burdick
Journal:  J Mech Behav Biomed Mater       Date:  2013-12-04

Review 9.  Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.

Authors:  Yan Wang; Jin-Lin Hou
Journal:  Hepatol Int       Date:  2016-01-07       Impact factor: 6.047

10.  Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.

Authors:  Michael Sørensen; Kasper S Mikkelsen; Kim Frisch; Gerda E Villadsen; Susanne Keiding
Journal:  J Hepatol       Date:  2013-01-20       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.